Alnylam Pharmaceuticals, Inc.ALNYNASDAQ
LOADING
|||
Net Income Growth Under Pressure
Trending lower, above historical average, modest growth trend.
Left:
||||
Year-over-year net income growth rate
Latest
36.82%
↑ 936% above average
Average (9y)
-4.40%
Historical baseline
Range
High:61.08%
Low:-55.13%
CAGR
+7.3%
Consistent expansion
| Period | Value |
|---|---|
| 2024 | 36.82% |
| 2023 | 61.08% |
| 2022 | -32.64% |
| 2021 | 0.64% |
| 2020 | 3.14% |
| 2019 | -16.37% |
| 2018 | -55.13% |
| 2017 | -19.69% |
| 2016 | -41.38% |
| 2015 | 19.51% |